LFMD Q1 2024 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena

LFMDLifeMD, Inc.

$182M

Q1 2024 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$44M+33.3% YoY

Gross Profit

$40M89.6% margin

Operating Income

-$6M-14.0% margin

Net Income

-$7M-15.3% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

-1.6%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$3M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$61M

Total Liabilities

$60M

Stockholders' Equity

-$845,303

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$44M	$33M	+33.3%
Gross Profit	$40M	$29M	+36.8%
Operating Income	-$6M	-$3M	-116.3%
Net Income	-$7M	-$4M	-68.9%